Pfizer Inc. closed $4.92 short of its 52-week high ($31.54), which the company reached on July 30th.

Pfizer has agreed to reimburse BioNTech for $364.5 million of the claimed royalties paid to NIH and $170.0 million of the claimed royalties paid to the University of Pennsylvania. Write to Dean Seal ...

Concurrently, the company has amended its license agreements to provide for a low single-digit percentage royalty on Net Sales of Licensed Products for 2024 onwards. Currently, BioNTech's stock is ...

In a regulatory filing, BioNTech (BNTX) said, “BioNTech previously disclosed that it was in discussions with the University of Pennsylvania ...

Investors love dividend stocks, especially the blue-chip variety because they ... and paints and coatings applications.

Ken Shreve and Ed Carson analyze Thursday's market action and discuss key stocks to watch on Stock Market Today.

Meme stocks like AMC and GameStop get their price spikes from strong buying interest. GameStop jumped Thursday morning after ...

This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...

Plenty of high-performing growth stocks pay dividends -- such as Apple and Nvidia -- and though their dividend yields can be ...

High-yield dividend stocks often catch investors' attention -- and for good reason. When established companies maintain ...

Shares of Pfizer Inc. PFE inched 0.11% higher to $26.74 Tuesday, on what proved to be an all-around great trading session for ...